Literature DB >> 18358709

GATA-3 and the regulation of the mammary luminal cell fate.

Hosein Kouros-Mehr1, Jung-whan Kim, Seth K Bechis, Zena Werb.   

Abstract

The GATA family of transcription factors plays essential roles in the specification and maintenance of differentiated cell types. GATA-3 was identified in a microarray screen of the mouse mammary gland as the most highly expressed transcription factor in the mammary epithelium and is expressed exclusively in the luminal epithelial cell population. Targeted deletion of GATA-3 in mammary glands leads to profound defects in mammary development and inability to specify and maintain the luminal cell fate in the adult mouse. In breast cancer, GATA-3 has emerged as a strong predictor of tumor differentiation, estrogen-receptor status, and clinical outcome. GATA-3 maintains tumor differentiation and suppresses tumor dissemination in a mouse model of breast cancer. This review explores our current understanding of GATA-3 signaling in luminal cell differentiation, both in mammary development and breast cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358709      PMCID: PMC2397451          DOI: 10.1016/j.ceb.2008.02.003

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  57 in total

1.  Function of GATA transcription factors in preadipocyte-adipocyte transition.

Authors:  Q Tong; G Dalgin; H Xu; C N Ting; J M Leiden; G S Hotamisligil
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

2.  Generation of a functional mammary gland from a single stem cell.

Authors:  Mark Shackleton; François Vaillant; Kaylene J Simpson; John Stingl; Gordon K Smyth; Marie-Liesse Asselin-Labat; Li Wu; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nature       Date:  2006-01-05       Impact factor: 49.962

Review 3.  Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state.

Authors:  Kelly A Green; Jason S Carroll
Journal:  Nat Rev Cancer       Date:  2007-09       Impact factor: 60.716

4.  Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation.

Authors:  I Satokata; L Ma; H Ohshima; M Bei; I Woo; K Nishizawa; T Maeda; Y Takano; M Uchiyama; S Heaney; H Peters; Z Tang; R Maxson; R Maas
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

5.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

6.  FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium.

Authors:  S G Tevosian; A E Deconinck; M Tanaka; M Schinke; S H Litovsky; S Izumo; Y Fujiwara; S H Orkin
Journal:  Cell       Date:  2000-06-23       Impact factor: 41.582

7.  Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.

Authors:  S Gruvberger; M Ringnér; Y Chen; S Panavally; L H Saal; M Fernö; C Peterson; P S Meltzer
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

8.  Gene expression profiling of primary breast carcinomas using arrays of candidate genes.

Authors:  F Bertucci; R Houlgatte; A Benziane; S Granjeaud; J Adélaïde; R Tagett; B Loriod; J Jacquemier; P Viens; B Jordan; D Birnbaum; C Nguyen
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

9.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

10.  The transcription factor GATA6 is essential for branching morphogenesis and epithelial cell differentiation during fetal pulmonary development.

Authors:  R Keijzer; M van Tuyl; C Meijers; M Post; D Tibboel; F Grosveld; M Koutsourakis
Journal:  Development       Date:  2001-02       Impact factor: 6.868

View more
  74 in total

Review 1.  Polycomb group proteins: navigators of lineage pathways led astray in cancer.

Authors:  Adrian P Bracken; Kristian Helin
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

2.  Genomic antagonism between retinoic acid and estrogen signaling in breast cancer.

Authors:  Sujun Hua; Ralf Kittler; Kevin P White
Journal:  Cell       Date:  2009-06-26       Impact factor: 41.582

3.  Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma.

Authors:  S J Cooper; H Zou; S N Legrand; L A Marlow; C A von Roemeling; D C Radisky; K J Wu; N Hempel; V Margulis; H W Tun; G C Blobe; C G Wood; J A Copland
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

4.  Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor α gene through GATA-binding protein 3 (GATA3).

Authors:  Jin Qi; Lei Huo; Yiwei Tony Zhu; Yi-Jun Zhu
Journal:  J Biol Chem       Date:  2014-09-25       Impact factor: 5.157

5.  Unraveling the regulatory connections between two controllers of breast cancer cell fate.

Authors:  Jinho Lee; Abhinav Tiwari; Victor Shum; Gordon B Mills; Michael A Mancini; Oleg A Igoshin; Gábor Balázsi
Journal:  Nucleic Acids Res       Date:  2014-05-03       Impact factor: 16.971

6.  JARID1B is a luminal lineage-driving oncogene in breast cancer.

Authors:  Shoji Yamamoto; Zhenhua Wu; Hege G Russnes; Shinji Takagi; Guillermo Peluffo; Charles Vaske; Xi Zhao; Hans Kristian Moen Vollan; Reo Maruyama; Muhammad B Ekram; Hanfei Sun; Jee Hyun Kim; Kristopher Carver; Mattia Zucca; Jianxing Feng; Vanessa Almendro; Marina Bessarabova; Oscar M Rueda; Yuri Nikolsky; Carlos Caldas; X Shirley Liu; Kornelia Polyak
Journal:  Cancer Cell       Date:  2014-06-16       Impact factor: 31.743

7.  Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.

Authors:  Martin S Denzel; Lionel W Hebbard; Gregory Shostak; Lawrence Shapiro; Robert D Cardiff; Barbara Ranscht
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

8.  Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop.

Authors:  Crystal N Marconett; Shyam N Sundar; Kevin M Poindexter; Theresa R Stueve; Leonard F Bjeldanes; Gary L Firestone
Journal:  Mol Biol Cell       Date:  2010-02-03       Impact factor: 4.138

9.  Reprogramming cell fates in the mammary microenvironment.

Authors:  Corinne A Boulanger; Gilbert H Smith
Journal:  Cell Cycle       Date:  2009-04-12       Impact factor: 4.534

10.  GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion.

Authors:  Jianwei Sun; Huifang He; Smitha Pillai; Yin Xiong; Sridevi Challa; Liyan Xu; Srikumar Chellappan; Shengyu Yang
Journal:  J Biol Chem       Date:  2013-11-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.